4//SEC Filing
FERRANTE DOMENIC J 4
Accession 0001209191-21-023073
CIK 0001733257other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 6:04 PM ET
Size
17.3 KB
Accession
0001209191-21-023073
Insider Transaction Report
Form 4
FERRANTE DOMENIC J
Director
Transactions
- Conversion
Series D Preferred Stock
2021-03-23−90,378→ 0 total(indirect: See footnote)→ Common Stock (90,378 underlying) - Conversion
Series C Preferred Stock
2021-03-23−300,948→ 0 total(indirect: See footnote)→ Common Stock (300,948 underlying) - Conversion
Common Stock
2021-03-23+90,378→ 533,254 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2021-03-23−141,928→ 0 total(indirect: See footnote)→ Common Stock (141,928 underlying) - Conversion
Common Stock
2021-03-23+141,928→ 141,928 total(indirect: See footnote) - Purchase
Common Stock
2021-03-23$17.00/sh+102,941$1,749,997→ 636,195 total(indirect: See footnote) - Conversion
Common Stock
2021-03-23+300,948→ 442,876 total(indirect: See footnote)
Footnotes (2)
- [F1]Each share of Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
- [F2]The securities are held by The Domenic J. Ferrante 2006 Investment Trust (the "Trust"). The Reporting Person is the trustee of the Trust.
Documents
Issuer
Finch Therapeutics Group, Inc.
CIK 0001733257
Entity typeother
Related Parties
1- filerCIK 0001213397
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 6:04 PM ET
- Size
- 17.3 KB